NEO
NeoGenomics Inc
17.20$
+1.9%
vs. previous close
Closing price · As of: Nov 4, 2026
Statements
Income Statement
NeoGenomics Inc (NEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Revenue" came in at 209 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 156 | 156 | 165 | 168 | 172 | 168 | 181 | 188 | 190 | 187 | 202 | 209 | 788 | |
| 88 | 91 | 92 | 93 | 95 | 95 | 104 | 107 | 114 | 106 | 110 | 113 | 443 | |
| 68 | 65 | 72 | 75 | 77 | 73 | 77 | 80 | 76 | 81 | 92 | 97 | 345 | |
| 7.1 | 7.6 | 7.9 | 7.7 | 8.0 | 10 | 9.0 | 8.7 | 9.2 | 9.5 | 11 | 9.9 | 39 | |
| 60 | 66 | 63 | 67 | 64 | 65 | 72 | 70 | 64 | 66 | 64 | 67 | 260 | |
| 86 | 96 | 94 | 96 | 96 | 101 | 125 | 107 | 87 | 99 | 102 | 105 | 392 | |
| -19 | -31 | -22 | -21 | -18 | -28 | -48 | -27 | -11 | -18 | -9.8 | -7.9 | -47 | |
| 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 0.9 | 0.6 | 0.6 | 0.6 | 0.8 | 1.3 | 3.2 | |
| -15 | -28 | -19 | -18 | -16 | -26 | -46 | -26 | -12 | -18 | 1.8 | -8.0 | -36 | |
| -1.0 | -0.6 | -0.4 | -0.2 | -0.8 | 0.3 | -0.7 | 0.7 | -2.5 | -0.5 | -0.4 | -0.5 | -3.9 | |
| -14 | -27 | -19 | -18 | -15 | -26 | -45 | -27 | -9.9 | -17 | 2.2 | -7.5 | -32 | |
| 4.8 | -7.7 | 0.8 | 1.8 | 3.7 | -6.3 | -28 | -10.0 | 4.6 | -0.6 | 19 | 9.4 | 32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.